IRHYTHM HOLDINGS INC
IRTCNASDAQTrading Snapshot
- Day Range
- $113.06 β $116.21
- 52-Week Range
- $100.85 β $212.00
- Volume
- $3.67B
- Avg Volume
- $4.32B
- Shares Outstanding
- 32.9M
- Next Earnings
- Nov 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $747M
- Last Q Revenue
- $224M
- P/E Ratio
- -256.7
- P/S Ratio
- 4.4x
- EPS (TTM)
- $-0.42
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +6.3%
Why Investors Own IRTC
- βHigh-growth profile β revenue up +56.0% YoY with expanding US Equity exposure.
- βHealthy economics β 52% gross margin and 27% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
IRHYTHM HOLDINGS INC
IRTCAbout IRHYTHM HOLDINGS INC
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensorβspecifically embodied in products like the Zio XT and AT monitorsβwith a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
IRHYTHM HOLDINGS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift IRTC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
IRHYTHM HOLDINGS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.